Gamer.Site Web Search

Search results

1. Results From The WOW.Com Content Network

2. Meta's Ray-Ban glasses are about to get a lot smarter

   www.aol.com/finance/metas-ray-ban-meta-glasses...

   The updates make the Ray-Ban Meta Glasses, which start at $299, a far more intelligent piece of technology—and give them similar features to smartphone-based AI apps like Google's (GOOG, GOOGL ...

3. Ray-Ban - Wikipedia

   en.wikipedia.org/wiki/Ray-Ban

   Ray-Ban is a brand of luxury sunglasses and eyeglasses created in 1936 by Bausch & Lomb. The brand is best known for its Wayfarer and Aviator lines of sunglasses. In 1999, Bausch & Lomb sold the brand to Italian eyewear conglomerate Luxottica Group for a reported $640 million.

4. Ray-Ban Meta - Wikipedia

   en.wikipedia.org/wiki/Ray-Ban_Meta

   Ray-Ban Meta is a range of smartglasses created by Meta Platforms and EssilorLuxottica. They include two cameras, open-ear speakers, a microphone, and touchpad built into the frame. [ 1 ] They are latest in a line of smartglasses released by major companies including Snap Inc and Google and are designed as one component of Facebook’s plans ...

5. Older migraine drugs more effective than some newer options ...

   www.aol.com/older-migraine-drugs-more-effective...

   When looking at sustained freedom from pain, researchers found that eletriptan and ibuprofen were the most effective. Researchers concluded that eletriptan, rizatriptan, sumatriptan, and ...

6. Finasteride - Wikipedia

   en.wikipedia.org/wiki/Finasteride

   A 2010 Cochrane review found that men taking finasteride for BPH (with a mean age of 62.4) are at increased risk for impotence, erectile dysfunction, decreased libido, and ejaculation disorder for the first year of treatment. The rates became indistinguishable from placebo after 2–4 years and these side effects usually got better over time. [12]

7. Challenge to US drug price negotiation program revived by ...

   www.aol.com/news/challenge-us-drug-price...

   September 20, 2024 at 4:57 PM. By Brendan Pierson. (Reuters) - A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law requiring ...